New guidelines issued - Dallas Voice dallasvoice.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dallasvoice.com Daily Mail and Mail on Sunday newspapers.
The Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, was the lead site for a study evaluating Phase I and Phase III clinical trials for elacestrant, a treatment for postmenopausal women and adult men with ER+/HER2- advanced or metastatic breast cancer.
Mays Cancer Center Studies Lead to FDA Approval of Innovative Breast Cancer Drug miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
SAN ANTONIO, Texas (PRWEB) February 01, 2023 SAN ANTONIO (Feb. 1, 2023) The Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center,